Brief: Cero Therapeutics, Inc. Provides Corporate Update
21/10/2024 14:19
Oct 21 (Reuters) - CERo Therapeutics Holdings Inc
CERO.O :
* CERO THERAPEUTICS, INC. PROVIDES CORPORATE UPDATE
* CERO THERAPEUTICS HOLDINGS: TO ADJUST OUR PREVIOUS
GUIDANCE
ABOUT POTENTIAL ENTRY INTO CLINIC FROM 2024 TO EARLY 2025
Source text for Eikon: ID:nGNX510nm8
Further company coverage: CERO.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on CERo Therapeutics Holdings
See all newsBrief: Cero Therapeutics Hearing Review Council Issued Decision
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml (Certaint-1)
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Clinical Trial
Brief: Cero Therapeutics Holdings Inc - Continues To Evaluate Additional Options For Up-List